Literature DB >> 7209424

Treatment of cystinuria with alpha-mercaptopropionylglycine.

K Johansen, P A Gammelgård, F S Jørgensen.   

Abstract

Four cystinuric patients (3 females and 1 male) with recurrent L-cystine stone formation were treated with alpha-mercaptopropionyl glycine (MPG). In one patient the treatment was stopped because of a rash developing after one week of treatment. In the other 3 patients MPG was found to be as effective as penicillamine in lowering the urinary cystine excretion to safe levels. No serious side effects of the drug were recorded.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7209424     DOI: 10.3109/00365598009179559

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  3 in total

1.  Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus Statement.

Authors:  Brian H Eisner; David S Goldfarb; Michelle A Baum; Craig B Langman; Gary C Curhan; Glenn M Preminger; John C Lieske; Gyan Pareek; Kay Thomas; Anna L Zisman; Dimitri Papagiannopoulos; Roger L Sur
Journal:  J Endourol       Date:  2020-04-06       Impact factor: 2.942

2.  Myopathy due to mercaptopropionyl glycine.

Authors:  D S Hales; R Scott; H J Lewi
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-02

3.  Familial cystinuria in Ioannina District (Greece). Diagnosis and treatment.

Authors:  G Kallistratos; C Dimopoulos; V Kalfakakou-Vadalouka; A Evangelou; D Stockidis; P Vezyraki; C Charalambopoulos; I Mita
Journal:  Urol Res       Date:  1983
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.